Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP938295.RAARNDKzdTKM5Wntc3YOBHmfM-S-_DJxDX4yjDkzWBSpM130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938295.RAARNDKzdTKM5Wntc3YOBHmfM-S-_DJxDX4yjDkzWBSpM130_provenance.
• NP394202.RAHUmVXRhhBIP2GJCYx-TUoWRAbQ6vJ2Xdqp_LHtf8MYo130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394202.RAHUmVXRhhBIP2GJCYx-TUoWRAbQ6vJ2Xdqp_LHtf8MYo130_provenance.
• NP380306.RATvORcXrh0bdppCEsctt9egZJSRFC6LEXWQiIGRiiYgI130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380306.RATvORcXrh0bdppCEsctt9egZJSRFC6LEXWQiIGRiiYgI130_provenance.
• NP754432.RAZvcD5nBX-ZH-WTCqHVYU7qY-FX_Nu9leIcbE4teX5ys130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754432.RAZvcD5nBX-ZH-WTCqHVYU7qY-FX_Nu9leIcbE4teX5ys130_provenance.
• NP707732.RAM0-caOR44wzWG9moFOEodkvQP6UzQrmWAOFkPxeTqOY130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707732.RAM0-caOR44wzWG9moFOEodkvQP6UzQrmWAOFkPxeTqOY130_provenance.
• NP802201.RANRm_HcheIM2yiHGvcdRId4pfCDq7aV7h2oRAyxn0isE130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802201.RANRm_HcheIM2yiHGvcdRId4pfCDq7aV7h2oRAyxn0isE130_provenance.
• NP272877.RAU4U-MP5_E4TeBk_dt-n30-mDELnPT-qprRa-SqQgekQ130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272877.RAU4U-MP5_E4TeBk_dt-n30-mDELnPT-qprRa-SqQgekQ130_provenance.
• NP754047.RA2xgB2vLhfcSaqEzNUgWtlLUZXSW9Kc0Sb_D3yf-znT0130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754047.RA2xgB2vLhfcSaqEzNUgWtlLUZXSW9Kc0Sb_D3yf-znT0130_provenance.
• NP272874.RAMgWZy0cgBUDOb65tlBq64_uIVIjmQqeUE3ZvAVWbnzM130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272874.RAMgWZy0cgBUDOb65tlBq64_uIVIjmQqeUE3ZvAVWbnzM130_provenance.
• NP272871.RAwRmvt4heSnc53z2OGD4yorUYMnm0xA4tzH9JlS6HsUc130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272871.RAwRmvt4heSnc53z2OGD4yorUYMnm0xA4tzH9JlS6HsUc130_provenance.
• NP272879.RA3OwBRVNL7yIsx-UklYrih-R-Soav-DEfJgLnE9us2M0130_assertion description "[Immunohistochemical staining of c-erbB-2 (Neu) oncoprotein and mutant p53 protein on 45 cases of infiltrating duct carcinoma (IDC) of the breast revealed 33% membrane positivity of c-erbB-2 oncoprotein, 46% nuclear positivity of mutated p53 protein, 33% and 84% membrane positivity of EGF-R and EMA respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272879.RA3OwBRVNL7yIsx-UklYrih-R-Soav-DEfJgLnE9us2M0130_provenance.